Reau, Nancy <br/><br/>
Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C.  [electronic resource] 

 -  The American journal of gastroenterology  Mar 2011 
 - 452-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.1038/ajg.2010.424  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Drug Carriers<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Polyethylene Glycols--administration & dosage<br/>Polymerase Chain Reaction<br/>RNA, Viral--isolation & purification<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Treatment Failure<br/>Treatment Outcome<br/>Viral Load--drug effects